The Measurement Gap in Medicine - Injectable Sensors That Could Change Everything - Dr. Ben Hwang, CEO, Profusa

Send us Fan MailDr. Ben Hwang, Ph.D. is Chairman and CEO of Profusa ( https://profusa.com/ ), a pioneering bioengineering company developing tissue-integrated biosensors designed to continuously measure key chemical markers within the body. Profusa’s mission is to make our body’s chemistry as accessible as heart rate or step count — transforming personal and societal health through real-time molecular insight.Dr. Hwang has spent his career at the frontier where life science tools, digital systems, and global markets intersect. As an undergraduate research fellow in the laboratory of systems biology pioneer Leroy Hood at California Institute of Technology, he witnessed firsthand how transformative technologies can redefine biology.Dr. Hwang later held multiple senior leadership roles at Life Technologies (now part of Thermo Fisher Scientific), including President of Asia Pacific and Head of the qPCR Division — helping scale molecular biology platforms globally during a pivotal period for genomics and diagnostics.Earlier in his career, Dr. Hwang worked at McKinsey & Company and even began in professional sports with the Los Angeles Dodgers — an unusual trajectory that informs his leadership perspective today.Dr. Hwang earned his M.A. and Ph.D. in Biology from Johns Hopkins University.#DigitalHealth #Longevity #Biosensors #ContinuousMonitoring #FutureOfMedicine #HealthcareInnovation #WearableTech #Biotechnology#PrecisionMedicine #HumanOptimization #HealthTech #PreventiveMedicine#AgingResearch #Biohacking #MedicalInnovation #MetabolicHealth #Hypoxia #Mitochondria #ChronicDisease #FutureOfHealthcareSupport the show